These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16005307)
1. Monte Carlo estimates of natural variation in HIV infection. Heffernan JM; Wahl LM J Theor Biol; 2005 Sep; 236(2):137-53. PubMed ID: 16005307 [TBL] [Abstract][Full Text] [Related]
2. Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells. Heffernan JM; Wahl LM J Theor Biol; 2006 Nov; 243(2):191-204. PubMed ID: 16876200 [TBL] [Abstract][Full Text] [Related]
3. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment. Shi V; Tridane A; Kuang Y J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity analysis of a nonlinear lumped parameter model of HIV infection dynamics. Bortz DM; Nelson PW Bull Math Biol; 2004 Sep; 66(5):1009-26. PubMed ID: 15294416 [TBL] [Abstract][Full Text] [Related]
6. Modeling plasma virus concentration during primary HIV infection. Stafford MA; Corey L; Cao Y; Daar ES; Ho DD; Perelson AS J Theor Biol; 2000 Apr; 203(3):285-301. PubMed ID: 10716909 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation. Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652 [TBL] [Abstract][Full Text] [Related]
8. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000). Reading C; Dowding C; Schramm B; Garsd A; Onizuka-Handa N; Stickney D; Frincke J Clin Microbiol Infect; 2006 Nov; 12(11):1082-8. PubMed ID: 17002607 [TBL] [Abstract][Full Text] [Related]
9. A Bayesian approach to parameter estimation in HIV dynamical models. Putter H; Heisterkamp SH; Lange JM; de Wolf F Stat Med; 2002 Aug; 21(15):2199-214. PubMed ID: 12210633 [TBL] [Abstract][Full Text] [Related]
10. Virus immunocapture provides evidence of CD8 lymphocyte-derived HIV-1 in vivo. Hughes GJ; Willey SJ; Cochrane A; Leen C; Bell JE; Simmonds P AIDS; 2007 Jul; 21(12):1507-13. PubMed ID: 17630544 [TBL] [Abstract][Full Text] [Related]
11. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S; Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319 [TBL] [Abstract][Full Text] [Related]
12. Emergence of HIV-1 drug resistance during antiretroviral treatment. Rong L; Feng Z; Perelson AS Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401 [TBL] [Abstract][Full Text] [Related]
13. Modelling viral and immune system dynamics. Perelson AS Nat Rev Immunol; 2002 Jan; 2(1):28-36. PubMed ID: 11905835 [TBL] [Abstract][Full Text] [Related]
14. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation. Pippi F Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707 [TBL] [Abstract][Full Text] [Related]
15. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G; J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879 [TBL] [Abstract][Full Text] [Related]
16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
17. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment. Bento CA; Hygino J; Andrade RM; Saramago CS; Silva RG; Silva AA; Linhares UC; Brindeiro R; Tanuri A; Rosenzwajg M; Klatzmann D; Andrade AF AIDS; 2009 Jan; 23(1):9-18. PubMed ID: 19050381 [TBL] [Abstract][Full Text] [Related]
18. Mutation and control of the human immunodeficiency virus. Stengel RF Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629 [TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR; Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328 [TBL] [Abstract][Full Text] [Related]
20. Virus dynamics: the effect of target cell limitation and immune responses on virus evolution. Regoes RR; Wodarz D; Nowak MA J Theor Biol; 1998 Apr; 191(4):451-62. PubMed ID: 9631576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]